First patient dosed in Opti-GAIN, a first-in-human Phase I/II clinical trial of CTx001 in Geographic Atrophy secondary to AMD CTx001 is an investigational AAV-based gene therapy designed to deliver ...
A first-in-human clinical trial evaluating an investigational gene therapy targeting complement-mediated pathways in ...
C3G and IC-MPGN can be difficult to diagnose because they are so rare and their symptoms are vague and nonspecific. A kidney biopsy is considered the gold standard and usually needed to confirm the ...
Photoreceptors are specialized neurons that convert light into electrical signals that are processed in the visual cortex to form images. The RPE is a cell layer that is adjacent to the photoreceptors ...
Merck & Company Inc (NYSE:MRK) has announced a major acquisition involving Terns Pharmaceuticals, marking an important ...
Teva Pharmaceutical Industries continues to operate within a broad generic and specialty medicine landscape US market index ...
10d
Dame Doria Cordova Expands Money & You® to North America With New Course Offerings and Book Launch
The world’s longest-running entrepreneurial training program of 47 years brings expanded education to North America. For nearly five decades, we have watched entrepreneurs transform their businesses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results